Atricure Inc. buy UBS Group AG
Start price
30.10.24
/
50%
€29.29
Target price
30.10.25
€36.85
Performance (%)
-1.45%
Price
03.10.25
€28.87
Summary
This prediction is currently active. With a performance of -1.45%, the BUY prediction for Atricure Inc. by UBS_Group_AG is down slightly. This prediction currently runs until 30.10.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Atricure Inc. | -2.500% | -2.500% |
iShares Core DAX® | 2.709% | 3.108% |
iShares Nasdaq 100 | 0.867% | 4.580% |
iShares Nikkei 225® | 3.135% | 7.481% |
iShares S&P 500 | 0.886% | 3.550% |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $35.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat